337
Interest income 10,301 10,301 2,773 2,196 322
Interest expense -
convertible notes(3) (18,410) (25,563) (35,432) (35,439) (5,192)
Interest expense -
amortization of
convertible notes
issuance costs(3) (3,235) (2,969) (4,380) (4,381) (642)
Interest expense
- other (1,145) (1,145) -- -- --
Other income/
(expense), net (1,387) (1,387) 240 (255) (37)
Income/ (loss) before
income tax 79,723 72,836 19,866 (28,749) (4,212)
Income tax expense (14,423) (14,423) (16,919) (18,343) (2,687)
Income/ (loss)
from continuing
operations 65,300 58,413 2,947 (47,092) (6,899)
Income from
discontinued
operation 52,432 52,432 -- -- --
Net income/ (loss) 117,732 110,845 2,947 (47,092) (6,899)
Earnings/ (loss)
from continuing
operations per ADS
- basic 2.49 2.23 0.11 (1.78) (0.26)
- diluted(2) 2.43 2.20 0.11 (1.78) (0.26)
Earnings from
discontinued
operation
per ADS
- basic 2.00 2.00 N/A N/A N/A
- diluted(2) 2.02 1.98 N/A N/A N/A
Weighted average
number of ADS
- basic 26,242,974 26,242,974 26,324,842 26,432,974 26,432,974
- diluted(2)(3) 31,278,897 26,491,563 26,438,076 26,432,974 26,432,974
Notes:
(1) Revenues RMB'000 RMB'000 RMB'000 RMB'000 US$'000
- Immunodiagnostic
systems 122,160 122,160 110,491 76,833 11,256
- Molecular
diagnostic
systems 71,807 71,807 98,466 89,233 13,072
193,967
'/>"/>SOURCE China Medical Technologies, Inc. Copyright©2009 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Related medicine news :1.
China Shenghuo Reports Unaudited Financial Results for the Third Quarter of 20092.
Jiangbo Pharmaceuticals to Present at Brean Murray, Carret 2009 China Growth Conference3.
Novartis to Acquire Majority Stake in Hard to Treat Diseases (HTDS.PK) China Subsidiary H1N1 Vaccine Partner for US$125 Million4.
Simcere Pharmaceutical Group to Acquire China Manufacturing License for Rosuvastatin5.
HUYA Bioscience International Establishes Strategic Partnership with School of Medicine and Pharmacy, Ocean University of China6.
China Nepstar Enters Into Strategic Cooperation Agreement with ATMU to Install More Than 1,000 ATMs in Nepstar Stores7.
China Medical Technologies to Announce Unaudited Financial Results for the Second Fiscal Quarter Ended September 30, 2009 on November 19, 20098.
China Pharma Holdings, Inc. to Report Third Quarter 2009 Financial Results on November 12, 20099.
Perot Systems Announces Strategic Alliance With China Telecom10.
China Medicine Corporations Levocarnitine Dried Powder Injection Was Registered with the Ministry of Health of Pakistan11.
Niusule Launches Niusule Gummy Bears in China